These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23172224)

  • 1. The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins.
    Helwig M; Hoshino A; Berridge C; Lee SN; Lorenzen N; Otzen DE; Eriksen JL; Lindberg I
    J Biol Chem; 2013 Jan; 288(2):1114-24. PubMed ID: 23172224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7B2 chaperone knockout in APP model mice results in reduced plaque burden.
    Jarvela TS; Womack T; Georgiou P; Gould TD; Eriksen JL; Lindberg I
    Sci Rep; 2018 Jun; 8(1):9813. PubMed ID: 29955078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease.
    Hoshino A; Helwig M; Rezaei S; Berridge C; Eriksen JL; Lindberg I
    J Neurochem; 2014 Feb; 128(3):419-30. PubMed ID: 24102330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7B2 prevents unfolding and aggregation of prohormone convertase 2.
    Lee SN; Lindberg I
    Endocrinology; 2008 Aug; 149(8):4116-27. PubMed ID: 18467442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of islet amyloid polypeptide fibrillation and cytotoxicity by the secretory chaperones 7B2 and proSAAS.
    Peinado JR; Sami F; Rajpurohit N; Lindberg I
    FEBS Lett; 2013 Nov; 587(21):3406-11. PubMed ID: 24042052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
    Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice.
    Xu YH; Xu K; Sun Y; Liou B; Quinn B; Li RH; Xue L; Zhang W; Setchell KD; Witte D; Grabowski GA
    Hum Mol Genet; 2014 Aug; 23(15):3943-57. PubMed ID: 24599400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo designed protein inhibitors of amyloid aggregation and seeding.
    Murray KA; Hu CJ; Griner SL; Pan H; Bowler JT; Abskharon R; Rosenberg GM; Cheng X; Seidler PM; Eisenberg DS
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206240119. PubMed ID: 35969734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General Aggregation-Induced Emission Probes for Amyloid Inhibitors with Dual Inhibition Capacity against Amyloid β-Protein and α-Synuclein.
    Jia L; Wang W; Yan Y; Hu R; Sang J; Zhao W; Wang Y; Wei W; Cui W; Yang G; Lu F; Zheng J; Liu F
    ACS Appl Mater Interfaces; 2020 Jul; 12(28):31182-31194. PubMed ID: 32584021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?
    Windisch M; Hutter-Paier B; Schreiner E; Wronski R
    J Mol Neurosci; 2004; 24(1):155-65. PubMed ID: 15314265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seeding and propagation of lesions in neurodegenerative diseases: a new paradigm.
    Duyckaerts C; Seilhean D; Sazdovitch V; Plu I; Delatour B; Potier MC
    Bull Acad Natl Med; 2015 Jun; 199(6):809-819. PubMed ID: 29901881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation.
    Ahlemeyer B; Halupczok S; Rodenberg-Frank E; Valerius KP; Baumgart-Vogt E
    J Alzheimers Dis; 2018; 61(4):1425-1450. PubMed ID: 29376876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.
    Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; Kusters B; Maat-Schieman ML; de Waal RM; Verbeek MM
    Acta Neuropathol; 2006 Feb; 111(2):139-49. PubMed ID: 16485107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
    Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
    Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of protein aggregation in A53T α-synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice.
    Emmer KL; Covy JP; Giasson BI
    Neurosci Lett; 2012 Jan; 507(2):137-42. PubMed ID: 22188655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein aggregation containing β-amyloid, α-synuclein and hyperphosphorylated τ in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure.
    Chaves RS; Melo TQ; Martins SA; Ferrari MF
    BMC Neurosci; 2010 Nov; 11():144. PubMed ID: 21067569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal dysfunction in a mouse model of Sandhoff disease leads to accumulation of ganglioside-bound amyloid-β peptide.
    Keilani S; Lun Y; Stevens AC; Williams HN; Sjoberg ER; Khanna R; Valenzano KJ; Checler F; Buxbaum JD; Yanagisawa K; Lockhart DJ; Wustman BA; Gandy S
    J Neurosci; 2012 Apr; 32(15):5223-36. PubMed ID: 22496568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.
    Chouhan AK; Guo C; Hsieh YC; Ye H; Senturk M; Zuo Z; Li Y; Chatterjee S; Botas J; Jackson GR; Bellen HJ; Shulman JM
    Acta Neuropathol Commun; 2016 Jun; 4(1):62. PubMed ID: 27338814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
    J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.